Concepedia

Nan Huo

NH

Statistics

Publications

9

Citations

589

H-Index

9

Active since

2020

Affiliations

Peking University(Current)

Peking University First Hospital

University of Wisconsin–Madison

Chinese PLA General Hospital

Huazhong University of Science and Technology

Nan Huo is an author at Peking University specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

2020–2022

9

Publications

9

FOXO3A-induced LINC00926 suppresses breast tumor growth and metastasis through inhibition of PGK1-mediated Warburg effect

Zhong Chu, Nan Huo, Xiang Zhu et al. · Molecular Therapy · 2021 · 167 citations · Full text

, , +17

LSD1‐Demethylated LINC01134 Confers Oxaliplatin Resistance Through SP1‐Induced p62 Transcription in HCC

Luyuan Ma, An Xu, Lei Kang et al. · Hepatology · 2021 · 111 citations

, , +17

STAT3/LINC00671 axis regulates papillary thyroid tumor growth and metastasis via LDHA-mediated glycolysis

Nan Huo, Rui Cong, Zhi-Jia Sun et al. · Cell Death and Disease · 2021 · 105 citations · Full text

, , +16

DNMT3B-mediated FAM111B methylation promotes papillary thyroid tumor glycolysis, growth and metastasis

Xiang Zhu, Chunyuan Xue, Xiaofeng Kang et al. · International Journal of Biological Sciences · 2022 · 50 citations · Full text

, , +17

CD38‐Targeted Theranostics of Lymphoma with <sup>89</sup>Zr/<sup>177</sup>Lu‐Labeled Daratumumab

Lei Kang, Cuicui Li, Zachary T. Rosenkrans et al. · Advanced Science · 2021 · 49 citations · Full text

, , +17

1–5 of 9